Novocure (NVCR) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts NVCR Hot Sheet
Join SI Premium – FREE
Novocure (NASDAQ: NVCR) reported Q4 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $53.7 million versus the consensus estimate of $53.52 million.
For earnings history and earnings-related data on Novocure (NVCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
- Borr Drilling (BORR) Misses Q2 EPS by 69c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
